# Bryhali

NDC: 0187-0002
Generic name: halobetasol propionate
Labeler / Manufacturer: Bausch Health US, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: LOTION
Routes: TOPICAL
Marketing started: 20181106

FDA application: NDA209355

## Active ingredients

- HALOBETASOL PROPIONATE: .1 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0187-0002"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0187-0002
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4bbb66a-3f9d-4091-b1b0-1cbc908432d3